Letter: Active site directed inhibition of enzymes utilizing deaminatively produced carbonium ions. Application to chymotrypsin

E H White et al. J Am Chem Soc. 1975.

. 1975 Apr 16;97(8):2290-1.

doi: 10.1021/ja00841a061.

No abstract available

Similar articles

Active site-directed inhibition with substrates producing carbonium ions: chymotrypsin.
White EH, Roswell DF, Politzer IR, Branchini BR. White EH, et al. Methods Enzymol. 1977;46:216-20. doi: 10.1016/s0076-6879(77)46022-1. Methods Enzymol. 1977. PMID: 909409 No abstract available.
Irreversible enzyme inhibitors. 113. Proteolytic enzymes. 3. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides with an N-fluorosulfonylphenyl substituent.
Baker BR, Hurlbut JA. Baker BR, et al. J Med Chem. 1968 Mar;11(2):233-41. doi: 10.1021/jm00308a009. J Med Chem. 1968. PMID: 5654208 No abstract available.
Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
Baker BR, Hurlbut JA. Baker BR, et al. J Med Chem. 1969 Jan;12(1):118-22. doi: 10.1021/jm00301a030. J Med Chem. 1969. PMID: 5763006 No abstract available.
Affinity labeling via deamination reactions.
Sinnott ML. Sinnott ML. CRC Crit Rev Biochem. 1982 Apr;12(4):327-72. doi: 10.1080/10409238209104423. CRC Crit Rev Biochem. 1982. PMID: 6282535 Review.
Specific irreversible enzyme inhibitors.
Baker BR. Baker BR. Annu Rev Pharmacol. 1970;10:35-50. doi: 10.1146/annurev.pa.10.040170.000343. Annu Rev Pharmacol. 1970. PMID: 4986559 Review. No abstract available.